The Pharmacotherapy of "awakening"

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Disorders of consciousness (DOC) include coma, vegetative state (VS) and minimally conscious state (MCS). As revealed by functional imaging studies, clinical recovery is often associated with a functional restoration of cortico-thalamo-cortical connections. Depending on the amount of network restored, patients may regain full consciousness or remain in a MCS. Molecular and neural mediators may indirectly contribute to the above restoration processes owing to their role in the phenomenon of neural synaptic plasticity. Therefore, there is growing interest in the possible effects of drugs that act at the level of the CNS in promoting emergence from DOC. Pharmacological treatment has been attempted with various drugs, including levodopa, amphetamines, tricyclic antidepressants, amantadine, bromocriptine, anticonvulsants, and others. Levodopa and amantadine might be useful when parkinsonian features are present, but they are more likely to benefit patients in minimally conscious state than those in vegetative state. The present chapter is aimed at investigating the complex pharmacological management of DOC.

Original languageEnglish
Title of host publicationChronic Disorders of Consciousness: From Research to Clinical Practice
PublisherNova Science Publishers, Inc.
Pages102-115
Number of pages14
ISBN (Print)9781626189409
Publication statusPublished - 2013

Fingerprint

Persistent Vegetative State
Consciousness Disorders
Drug Therapy
Amantadine
Neuronal Plasticity
Levodopa
Pharmacology
Amphetamines
Bromocriptine
Tricyclic Antidepressive Agents
Coma
Consciousness
Pharmaceutical Preparations
Anticonvulsants

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Calabrò, R. S., Pollicino, P., & Bramanti, P. (2013). The Pharmacotherapy of "awakening". In Chronic Disorders of Consciousness: From Research to Clinical Practice (pp. 102-115). Nova Science Publishers, Inc..

The Pharmacotherapy of "awakening". / Calabrò, Rocco Salvatore; Pollicino, Patrizia; Bramanti, Placido.

Chronic Disorders of Consciousness: From Research to Clinical Practice. Nova Science Publishers, Inc., 2013. p. 102-115.

Research output: Chapter in Book/Report/Conference proceedingChapter

Calabrò, RS, Pollicino, P & Bramanti, P 2013, The Pharmacotherapy of "awakening". in Chronic Disorders of Consciousness: From Research to Clinical Practice. Nova Science Publishers, Inc., pp. 102-115.
Calabrò RS, Pollicino P, Bramanti P. The Pharmacotherapy of "awakening". In Chronic Disorders of Consciousness: From Research to Clinical Practice. Nova Science Publishers, Inc. 2013. p. 102-115
Calabrò, Rocco Salvatore ; Pollicino, Patrizia ; Bramanti, Placido. / The Pharmacotherapy of "awakening". Chronic Disorders of Consciousness: From Research to Clinical Practice. Nova Science Publishers, Inc., 2013. pp. 102-115
@inbook{3d87004a869c4f88a45ad24499cbfdcc,
title = "The Pharmacotherapy of {"}awakening{"}",
abstract = "Disorders of consciousness (DOC) include coma, vegetative state (VS) and minimally conscious state (MCS). As revealed by functional imaging studies, clinical recovery is often associated with a functional restoration of cortico-thalamo-cortical connections. Depending on the amount of network restored, patients may regain full consciousness or remain in a MCS. Molecular and neural mediators may indirectly contribute to the above restoration processes owing to their role in the phenomenon of neural synaptic plasticity. Therefore, there is growing interest in the possible effects of drugs that act at the level of the CNS in promoting emergence from DOC. Pharmacological treatment has been attempted with various drugs, including levodopa, amphetamines, tricyclic antidepressants, amantadine, bromocriptine, anticonvulsants, and others. Levodopa and amantadine might be useful when parkinsonian features are present, but they are more likely to benefit patients in minimally conscious state than those in vegetative state. The present chapter is aimed at investigating the complex pharmacological management of DOC.",
author = "Calabr{\`o}, {Rocco Salvatore} and Patrizia Pollicino and Placido Bramanti",
year = "2013",
language = "English",
isbn = "9781626189409",
pages = "102--115",
booktitle = "Chronic Disorders of Consciousness: From Research to Clinical Practice",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - The Pharmacotherapy of "awakening"

AU - Calabrò, Rocco Salvatore

AU - Pollicino, Patrizia

AU - Bramanti, Placido

PY - 2013

Y1 - 2013

N2 - Disorders of consciousness (DOC) include coma, vegetative state (VS) and minimally conscious state (MCS). As revealed by functional imaging studies, clinical recovery is often associated with a functional restoration of cortico-thalamo-cortical connections. Depending on the amount of network restored, patients may regain full consciousness or remain in a MCS. Molecular and neural mediators may indirectly contribute to the above restoration processes owing to their role in the phenomenon of neural synaptic plasticity. Therefore, there is growing interest in the possible effects of drugs that act at the level of the CNS in promoting emergence from DOC. Pharmacological treatment has been attempted with various drugs, including levodopa, amphetamines, tricyclic antidepressants, amantadine, bromocriptine, anticonvulsants, and others. Levodopa and amantadine might be useful when parkinsonian features are present, but they are more likely to benefit patients in minimally conscious state than those in vegetative state. The present chapter is aimed at investigating the complex pharmacological management of DOC.

AB - Disorders of consciousness (DOC) include coma, vegetative state (VS) and minimally conscious state (MCS). As revealed by functional imaging studies, clinical recovery is often associated with a functional restoration of cortico-thalamo-cortical connections. Depending on the amount of network restored, patients may regain full consciousness or remain in a MCS. Molecular and neural mediators may indirectly contribute to the above restoration processes owing to their role in the phenomenon of neural synaptic plasticity. Therefore, there is growing interest in the possible effects of drugs that act at the level of the CNS in promoting emergence from DOC. Pharmacological treatment has been attempted with various drugs, including levodopa, amphetamines, tricyclic antidepressants, amantadine, bromocriptine, anticonvulsants, and others. Levodopa and amantadine might be useful when parkinsonian features are present, but they are more likely to benefit patients in minimally conscious state than those in vegetative state. The present chapter is aimed at investigating the complex pharmacological management of DOC.

UR - http://www.scopus.com/inward/record.url?scp=84891993650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891993650&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84891993650

SN - 9781626189409

SP - 102

EP - 115

BT - Chronic Disorders of Consciousness: From Research to Clinical Practice

PB - Nova Science Publishers, Inc.

ER -